Fundamental and Technical Analysis of BIM.PA April 2025
Fundamental Analysis of BIM.PA April 2025
BioMérieux S.A. (BIM.PA) is a leading player in the diagnostics and research sector, specializing in in vitro diagnostic solutions for infectious diseases. The company, headquartered in Marcy-l’Étoile, France, has a strong presence in various regions including the Americas, Europe, the Middle East, Africa, and the Asia Pacific. With a diverse product portfolio that includes chromogen culture media, PCR systems, and automated identification systems, bioMérieux serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories.
Latest Quarterly and Annual Financial Results
As of the latest financial reports, bioMérieux has shown consistent growth in its revenue and profitability. The company’s total revenue for the fiscal year 2023 was €3,979,899,904, reflecting a 9.1% increase from the previous year. Net income for the same period was €432,200,000, indicating a robust financial performance.
Revenue, Profit, and Margin Trends
Over the past five years, bioMérieux has maintained a steady increase in revenue, driven by its innovative diagnostic solutions and expanding market reach. The company’s gross margins have also improved, currently standing at 55.66%, while its operating margins are at 16.82%. These figures highlight the company’s efficiency in managing costs and delivering high-quality products.
Beta (Monthly Over 5 Years)
The beta of BIM.PA is 0.531, indicating that the stock is less volatile than the overall market. This low beta suggests that bioMérieux’s stock price is relatively stable compared to the broader market, which can be an attractive trait for risk-averse investors.
Balance Sheet and Cash Flow
bioMérieux’s balance sheet reflects a strong financial position. The company has total assets of €4,498,000,000 and total liabilities of €4,907,000,000, resulting in a debt-to-equity ratio of 11.65. The company maintains a healthy cash position, with total cash of €449,800,000 and free cash flow of €297,787,488.
Important Financial Ratios
Key financial ratios for BIM.PA include:
- Price-to-Earnings (P/E) Ratio: 30.25
- Price-to-Book (P/B) Ratio: 3.09
- Return on Equity (ROE): 10.68%
- Return on Assets (ROA): 7.23%
- Dividend Yield: 0.78%
Technical Analysis of BIM.PA, April 2025
Stock Price Movement
Over the past year, the stock price of BIM.PA has shown a range from €88.25 to €120.00. The average daily volume has been around 119,420 shares, indicating moderate trading activity. The stock has experienced a 52-week change of 17.28%, reflecting its strong performance.
Common Technical Indicators
Technical indicators such as the Relative Strength Index (RSI) and Moving Average Convergence Divergence (MACD) provide insights into the stock’s momentum and trend direction. The RSI for BIM.PA has been in the oversold territory, indicating potential for a price rebound. The MACD line has crossed above the signal line, suggesting a bullish trend.
Current Trends and Potential Buy or Sell Signals
Based on the current trends, BIM.PA appears to be in an uptrend. The stock has formed a bullish engulfing pattern, which is a positive sign for investors. However, it is essential to monitor the trend invalidation level, which is currently set at €100.00.
Medium and Long-Term Price Target Recommendations
Analysts have set medium-term and long-term price targets for BIM.PA. The average medium-term price target is €125.07, while the long-term target is €130.00. These targets reflect the positive outlook for the company’s stock price.
Summary Table of Recommendations
| Investment Stance | Medium-Term Price Target | Long-Term Price Target | Trend Invalidation Level |
|---|---|---|---|
| Bullish | €125.07 | €130.00 | €100.00 |
Conclusion
In conclusion, bioMérieux S.A. (BIM.PA) presents a compelling investment opportunity with a strong fundamental profile and positive technical indicators. The company’s consistent revenue growth, efficient cost management, and low beta make it an attractive choice for investors seeking stability and growth.
FAQ
What is the current stock price of BIM.PA?
The current stock price of BIM.PA is €110.10.
What is the dividend yield of BIM.PA?
The dividend yield of BIM.PA is 0.78%.
What is the beta of BIM.PA?
The beta of BIM.PA is 0.531.
What are the medium-term and long-term price targets for BIM.PA?
The medium-term price target for BIM.PA is €125.07, and the long-term target is €130.00.
What is the trend invalidation level for BIM.PA?
The trend invalidation level for BIM.PA is €100.00.
Disclaimer: The information provided in this article is for educational and informational purposes only and should not be considered as financial advice. Trading involves risk, and past performance is not indicative of future results. Always conduct your own research or consult with a financial advisor before making investment decisions.